Expiring federal contract
75H70722P00094 — Cepheid
Department of Health and Human Services · Indian Health Service
- Contract / PIID
- 75H70722P00094
- Incumbent
- Cepheid
- Incumbent UEI
- W6HQTMWB9Q28
- Current end date
- February 28, 2027
- Potential total value
- $2,751,225
- Obligated
- $2,751,225
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Set-aside
- Full & Open
- Start date
- February 24, 2022
- Place of performance
- NM
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
ZSU CEPHEID GENEXPERT REQUIRES GROUP B REAGENTS KITS
Likely rebid window (estimate)
- Sources Sought / RFI: about Feb 2026 – Aug 2026 (6–12 months before the end date)
- RFP: about Oct 2026 – Dec 2026 (2–4 months before the end date)
Now inside the estimated RFP window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71025P00975 — Becton, Dickinson And Company · ends November 30, 2026 · $103K
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75N90026P00079 — Werfen USA LLC · ends January 31, 2027 · $170K
- 75H71226F28026 — Cepheid · ends February 7, 2027 · $272K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71025F80116 — Roche Diabetes Care INC · ends March 31, 2027 · $244K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75H70726F80013 — Fisher Scientific Company L.L.C. · ends April 30, 2027 · $610K
- 75A50123C00036 — Siro Diagnostics, INC. · ends May 1, 2027 · $28M